Search
for
Sort by
Research 61–90 of 760
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Psychoactive drugs and skin
- Primary cicatricial alopecia
- Lymphocytic mediated alopecia: histological classification by pattern analysis
- Evaluation of hair loss
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Histopathology of Scarring and Nonscarring Hair Loss
- Special Stains and Immunohistochemical Stains in Hair Pathology
- Cicatricial Alopecias
- Cutaneous drug reactions
- Non-Neoplastic Disorders of Hair
- Dermatological drugs, topical agents, and cosmetics
- Granzyme B in Autoimmune Skin Disease
- Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata
- The Link Between Obesity and the Skin
- Scarring Alopecias: Pathology and an Update on Digital Developments
- Trichoscopy in hair disorders in darker skin: An approach to diagnosis
- Review of Promising Off-Label Use of Deucravacitinib
- AUTOIMMUNE CICATRICIAL ALOPECIA AND THE ROLE OF TRICHOSCOPY IN ITS DIAGNOSIS: A LITERATURE REVIEW
- Moth eaten alopecia as a manifestation of group of skin diseases: Reporting a series of 100 cases
- Atypical Presentation of Lichen Planopilaris: Presentation of Two Cases and Review
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Skin manifestations associated with systemic diseases – Part I
- Red Dots in a Net-Like Pattern on the Upper Chest: A Novel Clinical Observation in Frontal Fibrosing Alopecia and Fibrosing Alopecia in Pattern Distribution
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Alopecias: Practical Tips for the Management of Biopsies and Main Diagnostic Clues for General Pathologists and Dermatopathologists
- Linear Lichen Planopilaris of the Face: Case Report and Review
- LETTERS TO THE EDITOR
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS